Wave Life Sciences, Inc. (WVE) Form SCHEDULE 13D/A — Aug 11, 2026

RA Capital Management, L.P., Peter Kolchinsky, Rajeev Shah and RA Capital Healthcare Fund, L.P. entered into a Joint Filing Agreement dated August 11, 2026, filed as Exhibit 99.1 to a Schedule 13D/A regarding common stock of Wave Life Sciences, Inc. (WVE). Under Rule 13d-1(k), the four filers agree to file a single Schedule 13D and/or 13G statement covering their combined beneficial ownership of Wave shares, with any member able to terminate the arrangement on one week's written notice.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.